tile blood flow in the thorax. Correlation coefficients were derived, and Bland-Altman analysis was performed to derive the mean percentage difference (MPD) between the devices. Results: 598 women were recruited for this study. In the normotensive group, 524 paired results were analysed, while 74 paired results were analysed in the hypertensive group. In the normotensive group, we found excellent correlation between USCOM ® and NICOM ® for HR (r = 0.885, p < 0.05), and moderate correlations for SV (r = 0.445, p < 0.05), CO (r = 0.529, p < 0.05), CI (r = 0.385, p < 0.05) and TPR (r = 0.524, p < 0.05). In the hypertensive group, we obtained similar correlations (HR: r = 0.877, p < 0.05; SV: r = 0.575, p < 0.05; CO: r = 0.601, p < 0.05; TPR: r = 0.589, p < 0.05). Bland-Altman analysis found that the agreement between both methodologies improved as gestation advances, with an MPD of 34% for CO estimation in the third trimester of uncomplicated pregnancies, and 39% in pregnancies complicated by hypertensive disorders. Conclusion: Our findings suggest that the two methodologies perform similarly in both uncomplicated pregnancies and in pregnancies complicated by hypertensive disorders. The study findings do not preclude the use of USCOM ® and NICOM ® devices in pregnancy, but indicate that these platforms cannot be used interchangeably. Our findings demonstrate an improvement in MPD as gestation advances and, therefore, questions the validity of previous
Introduction
Pregnancy is associated with an array of haemodynamic changes which include a fall in total peripheral resistance (TPR) and blood pressure (BP), and an increase in stroke volume (SV), cardiac output (CO) and heart rate (HR) [1] . Aberrations in maternal haemodynamics have been reported to occur weeks prior to the onset of complications such as preeclampsia and fetal growth restriction. Whilst maternal mortality in the UK is decreasing, sepsis, haemorrhage and preeclampsia are amongst the leading causes of direct maternal deaths [2] . These lifethreatening illnesses require early and aggressive fluid resuscitation in order to limit tissue hypoxia and thereby prevent end organ damage, ultimately the cause of maternal mortality. Equally, excessive fluid resuscitation can have significant respiratory and neurological sequelae, such as with preeclampsia.
Despite significant advances in our knowledge of shock, our clinical management is based on traditionally measured variables including pulse, peripheral BP, arterial oxygen saturation and central venous pressure. These act as surrogate markers for maternal SV and CO, which are fundamental to the appropriate management of the critically ill obstetric patient. We know that in the early stages of critical illness, these proxy markers exhibit minimal change [3] , and in a population consisting of largely young, medically fit women, decompensation in these surrogate variables is seen fairly late on in the disease process.
In previous decades, changes in maternal haemodynamics were investigated using dye dilution techniques and pulmonary artery catheterization (PAC) [4, 5] . CO measurement with a PAC using the bolus thermodilution method has been considered as the gold standard [6, 7] . Recently, there have been advances in the development and use of non-invasive CO monitoring devices. The technologies vary from ultrasound, carbon dioxide rebreathing, pulse contour analysis, bioimpedance and bioreactance. 
Methods

Study Population and Recruitment
This was a prospective, comparative study of 598 pregnant women. Women aged 16 years and over were recruited from routine antenatal clinics at our tertiary centre. Women with a history of congenital or acquired heart disease were excluded. Women who had a diagnosis of a hypertensive disorder of pregnancy according to ISSHP diagnostic criteria [8] , or who were found to have a mean arterial pressure >125 mm Hg at examination, were recruited to the hypertensive group. All subjects in the hypertensive group were in the third trimester. Written consent was obtained from all study participants, and research ethics committee approval (12/LO/0810) was obtained prior to performing the study investigations.
All non-invasive assessments were performed in the same room, under standardised conditions for the entire cohort. Subjects in the first and early second trimester (before 20 weeks' gestation) were assessed in supine position, while those in the late second trimester (after 20 weeks' gestation) and third trimester were assessed in a left lateral position. The investigating team received formal training on the correct use of USCOM ® and NICOM ® by representatives of the manufacturers.
Research Investigations
USCOM ® employs continuous-wave Doppler, with a non-imaging probe in the suprasternal notch to obtain velocity time integrals (VTIs) of transaortic or transpulmonary blood flow at the left or right ventricular outflow tract, respectively. Using an anthropometric algorithm, which correlates the outflow tract diameter with the patient's given height, USCOM ® uses the VTIs to compute SV and, therefore, CO and a complete haemodynamic profile. The USCOM ® probe was placed in the suprasternal notch to obtain VTIs of transaortic blood flow at the left ventricular outflow tract. Each acquisition used for analysis had a minimum of 2 consecutive Doppler profiles. Acquisitions with the least amount of interference and the best-quality VTIs were obtained in flow tracer mode. analyses the variations in frequency spectra (relative phase shifts) after delivering a transthoracic alternating current and uses several assumptions (about thoracic shape and fluid volumes) and algorithms to compute SV, CO and an array of haemodynamic parameters. The phase shifts are measured continuously and have been shown to correlate almost linearly to blood flow in the aorta [9] . NICOM ® surface electrodes were placed on participants (posterior aspect of the thorax) prior to them lying supine/in left lateral position, and readings were obtained simultaneously to US-COM ® readings. Following machine calibration, one complete haemodynamic profile was recorded for each patient.
Statistical Analysis
The Shapiro-Wilk test was performed on all data sets to assess the distribution of data. The correlation coefficients were expressed as either Pearson's (parametric data) or Spearman's correlation (non-parametric data). Categorical data were presented as number (%), while continuous data were presented as median and interquartile range. Bland-Altman analysis was performed, and the mean percentage difference (MPD) was calculated as a ratio of two standard deviations of the bias (limit of agreement) to the mean value of the variable between the two methodologies. If the MPD is <30%, then it is considered to be clinically acceptable, as proposed by Critchley and Critchley [6] . All statistical analysis was carried out using IBM SPSS Statistics version 21.
Results
A total of 598 paired results were obtained between October 2013 and September 2015. The demographic details of the cohort are shown in table 1 . The median values with the interquartile range for each of the variables in both groups are shown in table 2 . In order to assess the linear relationship between the two methodologies, cor- Table 1 . Baseline characteristics of the entire cohort consisting of the normotensive (n = 524) and hypertensive groups (n = 74) Figure 1 illustrates the scatterplots providing a visual demonstration of the correlation between the two methodologies for HR, SV, CO, CI and TPR in the normotensive pregnancies. Figure 2 illustrates the correlations in the pregnancies complicated by hypertensive disorders of pregnancy. The MPD between the two methodologies is presented in table 4 . Both devices showed high levels of correlation (normotensive group: r = 0.885, p < 0.05; hypertensive group: r = 0.877, p < 0.05) and agreement (MPD of 15 and 16%) for the estimation of HR in healthy and complicated pregnancies. The correlations for SV (normotensive group: r = 0.445, p < 0.05; hypertensive group: r = 0.575, p < 0.05), CO (normotensive group: r = 0.529, p < 0.05; hypertensive group: r = 0.601, p < 0.05), CI (normotensive group: r = 0.385, p < 0.05; hypertensive group: r = 0.312, p < 0.05) and TPR (normotensive group: r = 0.524, p < 0.05; hypertensive group: r = 0.589, p < 0.05) were similar in both groups.
Bland-Altman plots demonstrating the mean bias between the two methods and the 95% limits of agreement for each variable are shown for the normotensive ( fig. 3 ) and the hypertensive group ( fig. 4 ). In the normotensive group, the 95% limits of agreement was -14.95 to 10.77 bpm, and the mean bias was -2.09 bpm for HR, -32.77 to 37.93 ml and 2.58 ml for SV, -2.74 to 2.83 l/min and 0.04 l/min for CO, -1.68 to 1.52 l/min/m 2 and -0.08 l/min/m 2 for CI and -771.0 to 606.0 dyn×s×cm 5 and -83.0 dyn×s×cm 5 for TPR, respectively. In the pregnancies complicated by hypertensive disorders, the 95% limits of agreement was -16 to 12 bpm, with a mean bias of -2 bpm for HR, -31 to 30 ml and 0.2 ml for SV, -2.96 to 2.54 l/min and -0.2 l/min for CO, -1.8 to 1.28 l/min/m 2 and -0.26 l/min/m 2 for CI and -688 to 652 dyn×s×cm 5 and -18 dyn×s×cm 5 for TPR, respectively. The MPD was <30% for HR estimation, while it was >30% for the estimation of SV, CO, CI and TPR. Analysis of the control group by trimester demonstrates that the agreement between both methodologies improved as the pregnancy advances ( table 4 ) , with an observed MPD of 34% for CO estimation in the third trimester of healthy pregnancies and an MPD of 39% in pregnancies complicated by hypertensive disorders.
Both devices are able to deduce the CI [CO corrected for body surface area (BSA)]. Due to differences in device algorithms, both devices do not derive the same BSA, despite identical height and weight data being inputted in each device. NICOM ® calculates the BSA according to the Du Bois formula, while USCOM ® employs a different formula that gives a different BSA. Therefore, it is unsurprising that the CI has the weakest correlation (normotensive group: r = 0.385, p < 0.05; hypertensive group: r = 0.312, p < 0.05) of all the variables assessed. As a result, we did not analyse the SV index or TPR index in either group.
Discussion
Summary of the Study Findings
Our results suggest that there is a moderate correlation between USCOM ® and NICOM ® in recording SV, CO, CI and TPR, while that for HR was strong. Upon analysis of the data for each trimester, our findings suggest that the correlations for SV, CO, CI and TPR strengthen as the pregnancy advances. Similarly, the MPD revealed better agreement between the two methodologies in the third Correlation coefficients for each trimester and of the entire normotensive group are presented, along with the correlation coefficients in the hypertensive group consisting of pregnancies complicated by hypertensive disorders of pregnancy. 
Non-Invasive Haemodynamic Monitoring in Pregnancy
Interpretation of the Study Findings and Comparison with the Existing Literature
This is the first large, prospective study comparing two non-invasive methodologies in a large obstetric cohort consisting of both healthy and complicated pregnancies, ranging from 10 to 41 weeks of gestation. Our findings have shown that the two non-invasive methodologies perform similarly in normal and pathological pregnancies. This is an important finding as there would be little relevance if this technology performed differently in healthy compared to pathological pregnancies.
There is a paucity of data validating non-invasive technology in the pregnant population. Our group has conducted a comparison between non-invasive technology and transthoracic echocardiography, and we found acceptable levels of agreement between both methodologies and echocardiography in advanced pregnancy (manuscript currently undergoing peer review). Similar findings comparing USCOM ® to 3D echocardiography in advanced pregnancy have been reported [10] . The majority of studies in the non-pregnant population suggest that both USCOM ® and NICOM ® have an MPD exceeding the 30% threshold [11] [12] [13] [14] ; this appears to be similar in pregnancy.
Bland-Altman statistical analysis remains the most frequently used method of analysis when comparing two CO monitoring devices. While a threshold of <30% MPD has been stated to be clinically acceptable, this is applicable only when one is assessing a new device against a reference method or gold standard. An MPD of <30% implies that the devices can be used interchangeably, or that a new method can replace the reference method or gold standard. However in the current study, we are comparing two new methodologies against each other, and therefore, achieving a threshold <30% in this context is likely to be clinically irrelevant.
Study Limitations and Strengths
The main strength of our study is the large sample size and the wide range of gestational age at cardiovascular assessment (10-41 weeks of gestation), allowing us to assess correlation and agreement throughout pregnancy. A further strength of our study is that we have compared the two methodologies in both uncomplicated healthy and in pathological pregnancies, as ultimately, the primary research focus and clinical application of this technology will be in those complicated pregnancies. The main limitation of this study is that it compares two non-invasive methodologies with each other, without a reference method. Whilst we can assess the correlation and agreement between the two methods, it does not inform us of their accuracy against an accepted reference method.
Clinical and Research Implications
We have demonstrated that there is equal performance between the two methodologies in healthy pregnancies and in pregnancies complicated by hypertensive diseases. Our findings demonstrate that USCOM ® and NICOM ® cannot be used interchangeably in the pregnant population, due to the MPD being >30%. We have demonstrated the MPD for SV and CO estimation to be at least 50% in the first and second trimesters of pregnancy. This demonstrates an unacceptable level of variation for these plat- The MPD is the ratio of the limit of agreement (2 standard deviations of the bias between the two methods) and the mean value obtained by both methodologies. An MPD of <30% indicates that there is sufficient agreement between the two methodologies so that they may be used interchangeably, or so that one method can be replaced by another. MPDs for each trimester and of the entire normotensive group are presented, along with the MPD we found in the hypertensive group consisting of pregnancies complicated by hypertensive disorders of pregnancy. forms to be used interchangeably in a research or clinical setting. The variation in MPD with advancing gestation brings into question the validity and interpretation of longitudinal studies of maternal haemodynamics using these or similar platforms that have not been comprehensively validated in pregnancy. Further studies, ideally using a cross-sectional obstetric population and an accepted reference method, are required to ascertain whether the wide variation we have found in this study in the first two trimesters of pregnancy is attributable to the poor performance of one, or both platforms. Our work also highlights the need to devise specific reference ranges for each methodology (or device). We believe that further evaluation of these platforms is required before their use in research or the management of the critically unwell patient.
Conclusion
We have demonstrated excellent levels of correlation for HR, and moderate levels of correlation for SV, CO and TPR between Doppler ultrasound and bioreactance-derived haemodynamic indices in a large obstetric cohort. We found similar correlations in both healthy and pathological pregnancies, thereby suggesting that these devices can be utilised in normal pregnancies as well as in those complicated by hypertensive disorders. However, clinically acceptable agreement between the two methods is lacking, and, therefore, they cannot be used interchangeably. Further validation studies and establishing devicespecific reference ranges are needed before their application in research studies or the management of critically ill obstetric patients.
